HUP0302362A2 - Fejfájás, migrén, émelygés és hányás kezelésére alkalmas gyógyászati készítmény - Google Patents

Fejfájás, migrén, émelygés és hányás kezelésére alkalmas gyógyászati készítmény

Info

Publication number
HUP0302362A2
HUP0302362A2 HU0302362A HUP0302362A HUP0302362A2 HU P0302362 A2 HUP0302362 A2 HU P0302362A2 HU 0302362 A HU0302362 A HU 0302362A HU P0302362 A HUP0302362 A HU P0302362A HU P0302362 A2 HUP0302362 A2 HU P0302362A2
Authority
HU
Hungary
Prior art keywords
alkyl
straight
nausea
headache
vomiting
Prior art date
Application number
HU0302362A
Other languages
English (en)
Inventor
Raphael Barkan
Alexander Mirimsky
Original Assignee
Meditor Pharmaceuticals Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IL14463201A external-priority patent/IL144632A0/xx
Application filed by Meditor Pharmaceuticals Ltd. filed Critical Meditor Pharmaceuticals Ltd.
Publication of HUP0302362A2 publication Critical patent/HUP0302362A2/hu
Publication of HUP0302362A3 publication Critical patent/HUP0302362A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hospice & Palliative Care (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Otolaryngology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

A találmány tárgya S-alkil-izo-tio-urónium származékok, nem korlátozómódon ideértve az S-etil-izo-tio-urónium-dietil-foszfátot, a fejfájás(beleértve a migrént, de nem korlátozódva arra), illetve a hányásmegelőzésére, illetve kezelésére, különösen a migrénes tünetek, nemkorlátozó módon ideértve a fejfájást, émelygést és hányást,enyhítésére. A gyógyászati kompozíció hatékony fejfájás, migrén,émelygés, illetve hányás kezelésére, amely aktív hatóanyagként az (I)általános képletű vegyületet tartalmazza. A képletben R1 jelentése 1-8szénatomos, egyenes vagy elágazó láncú, telített vagy telítetlenalkiléncsoport, amely az alábbi csoportok közül lehet eggyel vagytöbbel helyettesítve: halogénatom, primer, szekunder vagy tercieramin, primer, szekunder vagy tercier alkohol, s a láncbanelőfordulhatnak az alábbi heteroatomok: O, N, S; R2, R3, R4 és R5jelentése egymástól függetlenül hidrogén, hidroxil, egyenes vagyelágazó szénláncú alacsonyabb szénatomszámú alkil, egyenes vagyelágazó szénláncú alacsonyabb szénatomszámú alkenil, egyenes vagyelágazó szénláncú alacsonyabb szénatomszámú alkinil, alacsonyabbszénatomszámú alkoxi, alkoxi-alkil, cikloalkil, cikloalkil-alkil,alacsony szénatomszámú tio-alkoxi, nitro, amino, ciano, szulfonil,halogénalkil, karbo-ariloxi, karbo-alkil-aril-oxi, alkil-szulfoxid,aril-szulfoxid, alkil-szulfon, aril-szulfon, alkil-szulfát, aril-szulfát, szulfonamid, tio-alkil, amely adott esetben halogénatommalvan szubsztituálva; A- jelentése fiziológiailag elviselhető anion. Ó
HU0302362A 2000-09-05 2001-08-30 Pharmaceutical compositions for headache, migraine, nausea and emesis HUP0302362A3 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US22981200P 2000-09-05 2000-09-05
IL14463201A IL144632A0 (en) 2001-07-30 2001-07-30 Method and pharmaceutical compositions for treating headache, nausea and migraine
PCT/IL2001/000817 WO2002019961A2 (en) 2000-09-05 2001-08-30 Pharmaceutical compositions for headache, migraine, nausea and emesis

Publications (2)

Publication Number Publication Date
HUP0302362A2 true HUP0302362A2 (hu) 2003-11-28
HUP0302362A3 HUP0302362A3 (en) 2005-05-30

Family

ID=26324036

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0302362A HUP0302362A3 (en) 2000-09-05 2001-08-30 Pharmaceutical compositions for headache, migraine, nausea and emesis

Country Status (22)

Country Link
US (2) US7148208B2 (hu)
EP (1) EP1315505B1 (hu)
JP (1) JP2004508311A (hu)
KR (1) KR100849999B1 (hu)
CN (1) CN100448439C (hu)
AT (1) ATE375797T1 (hu)
AU (2) AU2001286178B2 (hu)
BR (1) BR0113698A (hu)
CA (1) CA2420410C (hu)
CY (1) CY1107270T1 (hu)
DE (1) DE60131004T2 (hu)
DK (1) DK1315505T3 (hu)
ES (1) ES2296792T3 (hu)
HK (1) HK1058009A1 (hu)
HU (1) HUP0302362A3 (hu)
IL (1) IL154456A (hu)
MD (1) MD2447G2 (hu)
MX (1) MXPA03001737A (hu)
NO (1) NO20031902L (hu)
NZ (1) NZ524903A (hu)
PT (1) PT1315505E (hu)
WO (1) WO2002019961A2 (hu)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ524903A (en) * 2000-09-05 2004-11-26 Meditor Pharmaceuticals Ltd Pharmaceutical compositions comprising S-alkylisothiouronium derivatives for headache, migraine, nausea and emesis
WO2007108004A2 (en) * 2006-03-23 2007-09-27 Meditor Pharmaceuticals Ltd. S-alkylisothiouronium derivatives for the treatment of inflammatory diseases
EA200901591A1 (ru) * 2007-06-13 2010-06-30 Медитор Фармасьютикалс Лтд. Фармацевтические композиции производных s-алкилизотиоурония с маскированным вкусом
EP2219447B1 (en) * 2007-11-06 2013-07-03 Barkan-Farma S.r.l. S-alkylisothiouronium derivatives for treating uterine hypercontractility disorders
MD3619G2 (ro) * 2007-11-06 2009-01-31 Рафаэль Баркан Remediu medicamentos nazal cu acţiune anticongestivă
US9560967B2 (en) 2008-04-24 2017-02-07 The Invention Science Fund I Llc Systems and apparatus for measuring a bioactive agent effect
US9282927B2 (en) 2008-04-24 2016-03-15 Invention Science Fund I, Llc Methods and systems for modifying bioactive agent use
US20100069724A1 (en) * 2008-04-24 2010-03-18 Searete Llc Computational system and method for memory modification
US8682687B2 (en) 2008-04-24 2014-03-25 The Invention Science Fund I, Llc Methods and systems for presenting a combination treatment
US9449150B2 (en) 2008-04-24 2016-09-20 The Invention Science Fund I, Llc Combination treatment selection methods and systems
US20100063368A1 (en) * 2008-04-24 2010-03-11 Searete Llc, A Limited Liability Corporation Computational system and method for memory modification
US8876688B2 (en) 2008-04-24 2014-11-04 The Invention Science Fund I, Llc Combination treatment modification methods and systems
US8615407B2 (en) 2008-04-24 2013-12-24 The Invention Science Fund I, Llc Methods and systems for detecting a bioactive agent effect
US8930208B2 (en) 2008-04-24 2015-01-06 The Invention Science Fund I, Llc Methods and systems for detecting a bioactive agent effect
US8606592B2 (en) 2008-04-24 2013-12-10 The Invention Science Fund I, Llc Methods and systems for monitoring bioactive agent use
US9662391B2 (en) 2008-04-24 2017-05-30 The Invention Science Fund I Llc Side effect ameliorating combination therapeutic products and systems
US9239906B2 (en) 2008-04-24 2016-01-19 The Invention Science Fund I, Llc Combination treatment selection methods and systems
US9649469B2 (en) 2008-04-24 2017-05-16 The Invention Science Fund I Llc Methods and systems for presenting a combination treatment
US9064036B2 (en) 2008-04-24 2015-06-23 The Invention Science Fund I, Llc Methods and systems for monitoring bioactive agent use
US7974787B2 (en) * 2008-04-24 2011-07-05 The Invention Science Fund I, Llc Combination treatment alteration methods and systems
US9026369B2 (en) 2008-04-24 2015-05-05 The Invention Science Fund I, Llc Methods and systems for presenting a combination treatment
US20100130811A1 (en) * 2008-04-24 2010-05-27 Searete Llc Computational system and method for memory modification
US20090270687A1 (en) * 2008-04-24 2009-10-29 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Methods and systems for modifying bioactive agent use
US8357117B2 (en) * 2008-08-06 2013-01-22 Family Health International Device and method for delivering an agent into breast milk while breastfeeding
WO2012018341A1 (en) * 2010-08-05 2012-02-09 Family Health International Device and method for delivering an agent into breast milk while breastfeeding
CN109523244B (zh) * 2018-11-02 2023-06-27 创新先进技术有限公司 一种基于母子账户的用于转移款项数据的方法和系统

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2419675A1 (fr) * 1978-03-16 1979-10-12 Philagro Sa Compositions fongicides a base de phosphites d'isothiouronium
GB9418912D0 (en) * 1994-09-20 1994-11-09 Fisons Corp Pharmaceutically active compounds
MD263C2 (ro) * 1995-03-01 1995-12-31 Виктор ГИКАВЫЙ Remediu cu acţiune antihipotensivă "IZOTURON"
MD586C2 (ro) * 1995-05-25 1997-03-31 Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова Substanţă medicamentoasă cu acţiune antihipotensivă "Difetur"
FR2753098B1 (fr) * 1996-09-06 1998-11-27 Sod Conseils Rech Applic Composition pharmaceutique comprenant au moins un inhibiteur de no synthase et au moins un piegeur des formes reactives de l'oxygene
EP0928191B1 (en) * 1996-09-26 2002-08-28 Meditor Pharmaceuticals Ltd. Pharmaceutical compositions comprising s-alkylisothiouronium derivatives
WO1998019674A2 (en) * 1996-11-05 1998-05-14 Head Explorer Aps A method for treating tension-type headache
MD1138C2 (ro) * 1997-02-17 1999-07-31 Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова Izopropilfosfit-S-izopropilizotiuroniu- substanţă cu acţiune hipertensivă
MD1223C2 (ro) * 1997-07-15 2000-01-31 Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова Aplicarea dimetilfosfatului de S-metil-izo-tiouroniu în calitate de substanţă vasoconstrictoare şi preparat farmaceutic pe baza lui
US6127420A (en) * 1997-08-22 2000-10-03 The Medical College Of Wisconsin Research Foundation, Inc. L-N5 -(1-imino-3-alkenyl) ornithine and related compounds and use thereof
MD1431G2 (ro) * 1998-01-16 2001-02-28 Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова Remedii antihipotensive
US6093743A (en) * 1998-06-23 2000-07-25 Medinox Inc. Therapeutic methods employing disulfide derivatives of dithiocarbamates and compositions useful therefor
FR2788771B1 (fr) * 1999-01-22 2001-04-13 Pf Medicament Nouvelles 1,2-alcoyl-1-[1-[aryl (alcoyl) oxyalcoyl] piperidin-4-yl]-3-aryl isothiourees substituees, leur preparation et leur application en therapeutique
US6489308B1 (en) * 1999-03-05 2002-12-03 Trustees Of University Of Technology Corporation Inhibitors of serine protease activity, methods and compositions for treatment of nitric-oxide-induced clinical conditions
ATE399025T1 (de) * 1999-07-21 2008-07-15 Omeros Corp Spüllösungen und verfahren zur schmerzhemmung, entzündungshemmung und hemmung des knorpelabbaus
NZ524903A (en) * 2000-09-05 2004-11-26 Meditor Pharmaceuticals Ltd Pharmaceutical compositions comprising S-alkylisothiouronium derivatives for headache, migraine, nausea and emesis

Also Published As

Publication number Publication date
KR20030055257A (ko) 2003-07-02
KR100849999B1 (ko) 2008-08-01
MD2447F2 (en) 2004-05-31
BR0113698A (pt) 2003-12-09
NO20031902L (no) 2003-06-09
CY1107270T1 (el) 2012-11-21
CN100448439C (zh) 2009-01-07
US20070088005A1 (en) 2007-04-19
MXPA03001737A (es) 2004-09-10
AU2001286178B2 (en) 2006-09-14
MD2447G2 (ro) 2005-12-31
HUP0302362A3 (en) 2005-05-30
ATE375797T1 (de) 2007-11-15
MD20020139A (en) 2002-11-30
ES2296792T3 (es) 2008-05-01
WO2002019961A2 (en) 2002-03-14
US20040006044A1 (en) 2004-01-08
NZ524903A (en) 2004-11-26
WO2002019961A3 (en) 2002-08-15
EP1315505B1 (en) 2007-10-17
DE60131004D1 (de) 2007-11-29
CA2420410A1 (en) 2002-03-14
EP1315505A2 (en) 2003-06-04
CN1464788A (zh) 2003-12-31
IL154456A (en) 2013-05-30
HK1058009A1 (en) 2004-04-30
PT1315505E (pt) 2008-01-28
DE60131004T2 (de) 2008-07-31
JP2004508311A (ja) 2004-03-18
US7148208B2 (en) 2006-12-12
US8673979B2 (en) 2014-03-18
DK1315505T3 (da) 2008-03-03
NO20031902D0 (no) 2003-04-28
EP1315505A4 (en) 2006-02-22
CA2420410C (en) 2011-04-26
AU8617801A (en) 2002-03-22

Similar Documents

Publication Publication Date Title
HUP0302362A2 (hu) Fejfájás, migrén, émelygés és hányás kezelésére alkalmas gyógyászati készítmény
BR0317435A (pt) Derivados de pirimidina para o tratamento do crescimento celular anormal
BR0210464A (pt) Composto, composição farmacêutica, processo para preparar um composto, e, uso de um composto
CO5550421A2 (es) Derivados de indol utiles para el tratamiento de enfermeda- des
DK1389617T3 (da) Heterocyclisk forbindelse og antitumormiddel indeholdende denne som den aktive bestanddel
UY27368A1 (es) Nuevos compuestos
AR037329A1 (es) Compuestos pirazolo pirimidinona, procedimientos para la preparacion de los mismos, composiciones farmaceuticas de los mismos y usos de los mismos en la preparacion de medicamentos
BRPI0315188B8 (pt) composto e composição farmacêutica
MEP36508A (en) Triazolopyrazine derivatives useful as anti-cancer agents
BR0008770A (pt) Derivado de pirimidina, processo para a preparação de um derivado de pirimidina, processo para a produção de um efeito anti-câncer em um animal de sangue quente, uso de um derivado de pirimidina, e, composição farmacêutica
CA2309350A1 (en) Purine derivatives and medicaments comprising the same as active ingredient
NO20034011D0 (no) Steroider som agonister for FXR
HUP0201646A2 (hu) Új alfa-aminosav vegyületek, eljárás ezek előállítására, és ezeket tartalmazó gyógyászati készítmények
AP2001002307A0 (en) B3 adrenergic receptor agonists and uses thereof.
BR9908545A (pt) Derivado de piperidina, processo para a preparação do mesmo, composto, processo para a preparação do mesmo, e, composição farmacêutica
BRPI0414514A (pt) uso de um composto, composto, e, composições farmacêuticas
NO20050666L (no) 2,7-substituerte indoler og deres anvendelse som 5-HT6 modulatorer
TW200726470A (en) 6,7-unsaturated-7-carbamoylmorphinan derivatives
AR012489A1 (es) Tiofenopiridinas antagonistas del factor de liberacion de corticotropina. procedimiento para su preparacion, el uso de las mismas en la preparacionde un medicamento, composicion farmaceutica que las comprende, procedimiento para la preparacion de dicha composicion, un compuesto intermediario y
BRPI0310032B8 (pt) derivados de benzoxazina, seus usos e seus processos de produção, e composição farmacêutica
TR199701254T1 (xx) 5-HT al�� inhibit�r�n�n selektif 5-HT1A antagonistiyle kombinasyonu.
SE0201194D0 (sv) New compounds
MA28286A1 (fr) Dérivés de 1-N-phenyl-amino-1H-imidazole et compositions pharmaceutiques les contenant
MY138996A (en) 4-amino-5-cyanopyrimidine derivatives
HUP0303186A2 (hu) 4-Amino-benzopirán-származékok

Legal Events

Date Code Title Description
FA9A Lapse of provisional patent protection due to relinquishment or protection considered relinquished